Compounds > phenytoin
Page last updated: 2024-10-21

phenytoin and Metabolic Syndrome

phenytoin has been researched along with Metabolic Syndrome in 1 studies

Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Phabphal, K1
Geater, A1
Limapichart, K1
Sathirapanya, P1
Setthawatcharawanich, S1

Other Studies

1 other study available for phenytoin and Metabolic Syndrome

ArticleYear
Role of CYP2C9 polymorphism in phenytoin-related metabolic abnormalities and subclinical atherosclerosis in young adult epileptic patients.
    Seizure, 2013, Volume: 22, Issue:2

    Topics: Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Atherosclerosis; Cross-Sectional Studies; Cyt

2013